The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 04, 2013

Filed:

Jan. 23, 2009
Applicants:

Rajesh Jain, New Delhi, IN;

Sanjay Trehan, New Delhi, IN;

Jagattaran Das, New Delhi, IN;

Nishan Singh, New Delhi, IN;

Gurmeet Kaur Nanda, New Delhi, IN;

Sitaram Kumar Magadi, New Delhi, IN;

Sudhir Kumar Sharma, New Delhi, IN;

Inventors:

Rajesh Jain, New Delhi, IN;

Sanjay Trehan, New Delhi, IN;

Jagattaran Das, New Delhi, IN;

Nishan Singh, New Delhi, IN;

Gurmeet Kaur Nanda, New Delhi, IN;

Sitaram Kumar Magadi, New Delhi, IN;

Sudhir Kumar Sharma, New Delhi, IN;

Assignee:

Panacea Biotec Limited, New Delhi, IN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 243/14 (2006.01); C07D 403/06 (2006.01); C07D 413/12 (2006.01); C07D 487/04 (2006.01); A61K 31/551 (2006.01); A61P 3/10 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising compounds of Formula I and methods of treating or preventing one or more conditions that may be regulated or normalized via inhibition of dipeptidyl peptidase IV (DPP-IV).


Find Patent Forward Citations

Loading…